Inovio (INO) Down More Than 30% in 3 Months: Here's Why - Nasdaq

Inovio (INO) Down More Than 30% in 3 Months: Here's Why  Nasdaq

Shares of Inovio Pharmaceuticals, Inc. INO have declined sharply in the past three months. The stock has plunged 33.1%, wider than the industry's.



Comments

Popular posts from this blog

Types of skin cancer and how to spot them - Jersey's Best

What to do about skin tags, moles and other bumps - The Washington Post

STIs With Flu-Like Symptoms